IDEAS home Printed from https://ideas.repec.org/a/epw/ejmed0/v3y2021i1id40711.html

Safety and Efficacy of Antiviral Therapy of Chronic Hepatitis C in Chronic Kidney Disease and Hemodialysis Patients

Author

Listed:
  • W. Fadili

    (Cadi Ayyad University, Morocco)

  • A. Ait Errami

    (UHC Mohamed VI, Morocco)

  • S. Zaoui

    (UHC Mohamed VI, Morocco)

  • K. Elkassimi

    (UHC Mohamed VI, Morocco)

  • N. ElBouhi

    (UHC Mohamed VI, Morocco)

  • S. Oubaha

    (UHC Mohamed VI, Morocco)

  • Z. Samlani

    (UHC Mohamed VI, Morocco)

  • I. Laouad

    (UHC Mohamed VI, Morocco)

  • K. Krati

    (UHC Mohamed VI, Morocco)

Abstract

Background and Aims: To assess the efficacy and tolerability of sofosbuvir-based antiviral therapy for viral hepatitis C (HCV) patients with chronic kidney disease and on maintenance hemodialysis. Methods: We retrospectively reviewed all treated patients with HCV from January 2015 to November 2020. They were treated either with standard Interferon/Ribavirin or with Sofosbuvir combined to Daclatasvir or to Ledipasvir. We evaluated the sustained virologic response at 12 weeks (SVR12). Data were analyzed using SPSS 20.00. Results: Out of 61 patients, the mean age of our patients was 56,8±12,56 years and 42,6% were males. Six patients had eGFR

Suggested Citation

  • W. Fadili & A. Ait Errami & S. Zaoui & K. Elkassimi & N. ElBouhi & S. Oubaha & Z. Samlani & I. Laouad & K. Krati, 2021. "Safety and Efficacy of Antiviral Therapy of Chronic Hepatitis C in Chronic Kidney Disease and Hemodialysis Patients," European Journal of Medical and Health Sciences, European Open Science, vol. 3(1), pages 160-164, January.
    • Handle: RePEc:epw:ejmed0:v:3:y:2021:i:1:id:40711
    DOI: 10.24018/ejmed.2021.3.1.711
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/ejmed/article/view/40711
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/ejmed/article/download/40711/9110
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/ejmed.2021.3.1.711?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:3:y:2021:i:1:id:40711. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.